NCT00374881View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

August 31, 2007

Conditions
Acute Pain
Interventions
DRUG

Morphine

Morphine

DRUG

Morphine

Morphine low dose

DRUG

Sorbitol+Phenylephrine

Sorbitol+Phenylephrine

DRUG

Sorbitol+Phenylephrine+Morphine

Sorbitol+Phenylephrine+Morphine

DRUG

Sorbitol low concentration+Phenylephrine+Morphine

Sorbitol low concentration+Phenylephrine+Morphine

Trial Locations (2)

91120

Hadassah Hebrew University Medical Center, Department of Anesthesiology, Jerusalem

Unknown

Hadassah En Kerem Medical Centre, Jerusalem

Sponsors

Lead Sponsor

BioLineRx, Ltd.
All Listed Sponsors
lead

BioLineRx, Ltd.

INDUSTRY

NCT00374881 - A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects | Biotech Hunter | Biotech Hunter